Trillium Therapeutics Inc. (TRIL) Rose 5.26% or 0.17 To Price $3.4 On Thursday

Trillium Therapeutics Inc. (TRIL) rose 5.26% or 0.17 to $3.4. It is close to 38144 shares traded, which is 24.64% compare to the average total volume 154791. The market cap of TRIL is $49.94 million. The year to date change is -53.98%. The 52 week price range is from $2.83 to $13.3. Price of TRIL have changed -6.38% during last week. It have changed -24.88% over last month, -33.40% over last 3 months, -48.32% over last 6 months and -68.18% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 4.81. It is 41.47% above current price. The 200-day Moving Averages for TRIL is 6.03. It is 77.35% above current price. The 52-week High is 13.3. It is 291.18% from the current price. The 52-week Low is 2.83. It is -16.76% from current price.

There are some statistics of TRIL. It is has market cap $49.94 million. The share outstanding is 14.69 million. The average volume is 154791. The percent of top 15 Institution holding is 12.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is -250.06%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is -51.27%.


Share this post